Insmed (INSM) said Thursday it will redeem June 6 the entire $569.5 million aggregate principal amount of its remaining outstanding 0.75% Convertible Senior Notes due 2028.
The company will pay the redemption price in cash and equal to 100% of the principal amount of the notes outstanding on the redemption date, plus accrued and unpaid interest on the notes to, but excluding, the redemption date.
If noteholders choose to convert their notes to common shares, the company has elected to settle the conversions at any time prior to 5 pm ET June 4. As of April 24, the conversion rate of the notes is 30.7692 shares of common stock of the company per $1,000 principal amount of the notes, equivalent to a conversion price of about $32.50 per share.
Based on this conversion rate, an aggregate of up to 17.5 million common shares will be issued if all of the notes are converted, the company said.
Price: 69.55, Change: -1.25, Percent Change: -1.77
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。